Tizoptan eye drops bottle/dropper 3ml No. 1




Tizoptane is a drug used in ophthalmology. An antiglaucoma and miotic agent, for reducing intraocular pressure (IOP) in patients with open-angle glaucoma and intraocular hypertension with insufficient efficacy of monotherapy with beta-blockers or prostaglandin analogues for topical use.
Warehouse
1 ml of solution contains: bimatoprost - 0.3 mg, timolol maleate - 6.83 mg, equivalent to timolol 5 mg; excipients: benzalkonium chloride; citric acid, monohydrate; sodium hydrogen phosphate, heptahydrate; sodium chloride; hydrochloric acid; sodium hydroxide; water for injections.Contraindication
Hypersensitivity to timolol, bimatoprost and excipients included in the drug.
Respiratory tract hyperreactivity syndrome, including bronchial asthma in the acute stage and a history of episodes, severe chronic obstructive bronchopulmonary (COPD) diseases.
Sinus bradycardia, sick sinus syndrome, sinoatrial block, second and third degree atrioventricular block not controlled by a pacemaker, clinically pronounced heart failure, cardiogenic shock.
Method of application
Tizoptane should be applied topically to the eye.
Instill 1 drop into the conjunctival sac of the affected eye once a day, in the morning.
If the drug is administered once, the drug can be administered the next day. It is not recommended to exceed the dose - 1 injection once a day.
Application features
Like other ophthalmic drugs, Tizoptan can penetrate the systemic circulation. Due to the presence of timolol, a beta-adrenergic component, various types of adverse reactions (cardiovascular and respiratory) may occur, as with the use of systemic beta-blockers. The incidence of adverse reactions with topical administration of the drug is lower than with systemic administration.
Pregnant women
Tizoptane should be used during pregnancy only if the expected benefit to the mother outweighs the potential risk to the fetus.
Children
The drug should not be prescribed to patients under 18 years of age.
Drivers
Tizoptane has minor influence on the ability to drive or use machines. As with other ophthalmic drugs, if temporary blurred vision occurs during instillation, you should wait until vision clears before driving or using machines.
Overdose
There have been no reports of overdose with Tizoptan.
Side effects
From the nervous system: headache, dizziness.
On the part of the organs of vision: conjunctival hyperemia, superficial punctate keratitis, corneal erosion, burning sensation in the eyes, itching of the eyelids, tingling sensation in the eyes, foreign body sensation, dry eyes, erythema of the eyelids, eye pain, photophobia, eye discharge, visual impairment, visual acuity reduced, blepharitis, eyelid edema, eye irritation, lacrimation, eyelash growth. Iritis, conjunctival edema, eyelid pain, eye fatigue, trichiasis, corneal hyperpigmentation, eyelid ptosis, eyelid retraction, cystoid macular edema.
Respiratory, thoracic and mediastinal disorders: rhinitis, dyspnea, bronchospasm (especially in patients with existing bronchospasm diseases).
Storage conditions
Store at a temperature not exceeding 25°C.
Keep out of reach of children.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.